Healthcare markets for pain management and intensive care projected to grow by 2030

The global markets for chronic pain treatment and intensive care drugs are projected to see significant growth through 2030. The chronic pain treatment market is expected to reach $168.99 billion by 2030, growing at a CAGR of 9.1% from 2026. This expansion is driven by an aging population, rising rates of arthritis, and a shift toward non-opioid therapies and neuromodulation devices, such as closed-loop spinal cord stimulation systems.

Simultaneously, the intensive care drugs market is forecasted to reach $15.3 billion by 2030, with a CAGR of 6.1%. Growth in this sector is fueled by an increase in surgical procedures and the rising burden of chronic diseases. Key drivers include the integration of AI for real-time monitoring and dosage optimization, as well as expanded investment in intensive care unit (ICU) capabilities to manage life-threatening conditions like sepsis and acute respiratory distress syndrome.